Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bio Green Med Solution, Inc.CYCC · Entity 8225 | Director | June 30, 2023 | July 03, 2023 |
| LEXICON PHARMACEUTICALS, INC.LXRX · Entity 4970 | Director | June 03, 2026 | June 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bio Green Med Solution, Inc.
Report date June 30, 2023 · Filed July 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 40,415 |
Reported balance
After 2023-06-30 transaction · row 1
1 source rowRow 1 · 2023-06-30 · Grant · Acquired 21,219 · Balance 40,415 F1: The reporting person received an award of 21,219 restricted stock units on June 30, 2023, which shall vest in full on June 30, 2024. F2: These securities were granted to Dr. Barker for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.59 · Expires 2033-06-30 | Direct | 42,438 |
Reported balance
After 2023-06-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-06-30 · Grant · Acquired 42,438 · Balance 42,438 F2: These securities were granted to Dr. Barker for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person received an award of 21,219 restricted stock units on June 30, 2023, which shall vest in full on June 30, 2024.
F2: These securities were granted to Dr. Barker for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc.
LEXICON PHARMACEUTICALS, INC.
Report date June 03, 2026 · Filed June 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 213,771 |
Reported balance
After 2026-06-03 transaction · row 1
1 source rowRow 1 · 2026-06-03 · Exercise / conversion · Acquired 89,312 · Balance 213,771 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-06-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-03 · Exercise / conversion · Disposed 89,312 · Balance 0 F1: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2: Each restricted stock unit represents a contingent right to receive one share of common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
F2: Each restricted stock unit represents a contingent right to receive one share of common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2026 Filed Jun 4, 2026 20:11 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 89,312 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062822-26-000104 · form4.xml · derivative · entry 2 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 89,312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 20:11 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 89,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001062822-26-000104 · form4.xml · nonDerivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:32 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 43,478 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001062822-26-000084 · form4.xml · derivative · entry 2 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,478 Underlying: Common Stock · 43,478 shares Expires 2036-05-01 F3 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:32 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 35,714 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062822-26-000084 · form4.xml · derivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,714 Underlying: Common Stock · 35,714 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| June 03, 2025 Filed Jun 3, 2025 20:22 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 89,312 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-016465 · form4.xml · derivative · entry 2 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,312 Underlying: Common Stock · 89,312 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| June 03, 2025 Filed Jun 3, 2025 20:22 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 103,806 | $0.00 Strike: $0.62 | $0.00 |
DisclosureSEC source: 0001127602-25-016465 · form4.xml · derivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,806 Underlying: Common Stock · 103,806 shares Expires 2035-06-03 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| May 13, 2025 Filed May 13, 2025 21:50 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 36,810 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-014143 · form4.xml · derivative · entry 2 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,810 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 13, 2025 Filed May 13, 2025 21:50 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 36,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-014143 · form4.xml · nonDerivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2024 Filed May 13, 2024 20:01 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 36,810 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-015077 · form4.xml · derivative · entry 2 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,810 Underlying: Common Stock · 36,810 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 13, 2024 Filed May 13, 2024 20:01 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 44,906 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0001127602-24-015077 · form4.xml · derivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,906 Underlying: Common Stock · 44,906 shares Expires 2034-05-13 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| April 28, 2024 Filed Apr 29, 2024 20:17 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 8,032 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-013554 · form4.xml · derivative · entry 2 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,032 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 28, 2024 Filed Apr 29, 2024 20:17 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 8,032 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-013554 · form4.xml · nonDerivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,649 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2023 Filed Jul 3, 2023 20:57 UTC | Bio Green Med Solution, Inc. CYCC · Entity 8225 | GrantStock Option (right to buy) · Derivative | 42,438 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0001104659-23-077660 · tm2320411-8_4seq1.xml · derivative · entry 2 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,438 Underlying: Common Stock · 42,438 shares Expires 2033-06-30 F2 · price: These securities were granted to Dr. Barker for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc. Read SEC document |
| June 30, 2023 Filed Jul 3, 2023 20:57 UTC | Bio Green Med Solution, Inc. CYCC · Entity 8225 | GrantCommon Stock | 21,219 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-077660 · tm2320411-8_4seq1.xml · nonDerivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,415 F1 · shares: The reporting person received an award of 21,219 restricted stock units on June 30, 2023, which shall vest in full on June 30, 2024. F2 · price: These securities were granted to Dr. Barker for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc. Read SEC document |
| May 21, 2023 Filed May 22, 2023 20:02 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 9,302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-016430 · form4.xml · derivative · entry 2 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,302 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 21, 2023 Filed May 22, 2023 20:02 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 9,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-016430 · form4.xml · nonDerivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,617 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2023 Filed Apr 28, 2023 20:22 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 12,658 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001127602-23-013781 · form4.xml · derivative · entry 2 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,658 Underlying: Common Stock · 12,658 shares Expires 2033-04-28 F3 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| April 28, 2023 Filed Apr 28, 2023 20:22 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 8,032 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-013781 · form4.xml · derivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,032 Underlying: Common Stock · 8,032 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:10 UTC | Bio Green Med Solution, Inc. CYCC · Entity 8225 | GrantStock Option (right to buy) · Derivative | 31,645 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001104659-22-071892 · tm2218645-1_4seq1.xml · derivative · entry 2 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,645 Underlying: Common Stock · 31,645 shares Expires 2032-06-14 F2 · price: These options were granted to Dr. Barker for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:10 UTC | Bio Green Med Solution, Inc. CYCC · Entity 8225 | GrantCommon Stock | 15,822 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-071892 · tm2218645-1_4seq1.xml · nonDerivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,196 F1 · shares: The reporting person received an award of 15,822 restricted stock units on June 14, 2022, which shall vest in full on June 14, 2023. Read SEC document |
| May 21, 2022 Filed May 23, 2022 20:13 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 9,302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-015367 · form4.xml · derivative · entry 2 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,302 Underlying: Common Stock · 9,302 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 21, 2022 Filed May 23, 2022 20:13 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 14,402 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001127602-22-015367 · form4.xml · derivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,402 Underlying: Common Stock · 14,402 shares Expires 2032-05-21 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| April 30, 2022 Filed May 2, 2022 20:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 4,024 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012825 · form4.xml · derivative · entry 2 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,024 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 30, 2022 Filed May 2, 2022 20:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 4,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012825 · form4.xml · nonDerivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 21:07 UTC | Bio Green Med Solution, Inc. CYCC · Entity 8225 | SaleCommon Stock | 12 | $3.57 | $42.86 |
DisclosureSEC source: 0001104659-21-145913 · tm2134438-1_4seq1.xml · nonDerivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,374 F1 · shares: The reporting person sold 12 shares of common stock on November 30, 2021. Read SEC document |
| August 24, 2021 Filed Aug 25, 2021 20:16 UTC | Bio Green Med Solution, Inc. CYCC · Entity 8225 | PurchaseCommon Stock | 1,000 | $5.00 | $5,000.00 |
DisclosureSEC source: 0001104659-21-109337 · tm2125937-1_4seq1.xml · nonDerivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,386 F1 · shares: The reporting person purchased 1,000 shares of common stock on August 24, 2021. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 20:08 UTC | Bio Green Med Solution, Inc. CYCC · Entity 8225 | GrantStock Option (right to buy) · Derivative | 4,748 | $0.00 Strike: $6.69 | $0.00 |
DisclosureSEC source: 0001104659-21-082604 · tm2119990d6_4.xml · derivative · entry 2 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,748 Underlying: Common Stock · 4,748 shares Expires 2031-06-15 F2 · price: These options were granted to Dr. Barker for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 20:08 UTC | Bio Green Med Solution, Inc. CYCC · Entity 8225 | GrantCommon Stock | 2,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-082604 · tm2119990d6_4.xml · nonDerivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,386 F1 · shares: The reporting person received an award of 2,374 restricted stock units on June 15, 2021, which shall vest in full on June 15, 2022. Read SEC document |
| April 30, 2021 Filed May 3, 2021 21:02 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 6,475 | $0.00 Strike: $5.04 | $0.00 |
DisclosureSEC source: 0001127602-21-014962 · form4.xml · derivative · entry 2 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,475 Underlying: Common Stock · 6,475 shares Expires 2031-04-30 F3 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| April 30, 2021 Filed May 3, 2021 21:02 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 4,024 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014962 · form4.xml · derivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,024 Underlying: Common Stock · 4,024 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 24, 2021 Filed Apr 27, 2021 20:46 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 10,638 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014518 · form4.xml · derivative · entry 2 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 24, 2021 Filed Apr 27, 2021 20:46 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 10,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014518 · form4.xml · nonDerivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,291 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 22:48 UTC | Bio Green Med Solution, Inc. CYCC · Entity 8225 | GrantStock Option (right to buy) · Derivative | 5,200 | $0.00 Strike: $4.70 | $0.00 |
DisclosureSEC source: 0001104659-20-078120 · tm2023597d2_form4.xml · derivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,200 Underlying: Common Stock · 5,200 shares Expires 2030-06-25 F1 · price: These options were granted to Dr. Barker for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc. Read SEC document |
| April 26, 2020 Filed Apr 27, 2020 20:44 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 3,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014562 · form4.xml · derivative · entry 4 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,466 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 26, 2020 Filed Apr 27, 2020 20:44 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 3,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014562 · form4.xml · nonDerivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,653 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2020 Filed Apr 27, 2020 20:44 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 10,638 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014562 · form4.xml · derivative · entry 3 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,638 Underlying: Common Stock · 10,638 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 24, 2020 Filed Apr 27, 2020 20:44 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 18,115 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001127602-20-014562 · form4.xml · derivative · entry 2 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,115 Underlying: Common Stock · 18,115 shares Expires 2030-04-24 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| August 02, 2019 Filed Aug 2, 2019 20:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 12,000 | $1.18 | $14,160.00 |
DisclosureSEC source: 0001127602-19-025862 · form4.xml · nonDerivative · entry 2 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,187 Read SEC document |
| August 02, 2019 Filed Aug 2, 2019 20:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 12,000 | $1.17 | $14,040.00 |
DisclosureSEC source: 0001127602-19-025862 · form4.xml · nonDerivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,187 Read SEC document |
| May 29, 2019 Filed May 31, 2019 20:36 UTC | Bio Green Med Solution, Inc. CYCC · Entity 8225 | GrantStock Option (right to buy) · Derivative | 18,750 | $0.00 Strike: $0.64 | $0.00 |
DisclosureSEC source: 0001144204-19-029254 · tv522819_form4.xml · derivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Underlying: Common Stock · 18,750 shares Expires 2029-05-29 F1 · price: These options were granted to Dr. Barker for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc. Read SEC document |
| April 26, 2019 Filed Apr 29, 2019 21:01 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 3,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-016490 · form4.xml · derivative · entry 2 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,466 Underlying: Common Stock · 3,466 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 26, 2019 Filed Apr 29, 2019 21:01 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 6,519 | $0.00 Strike: $5.67 | $0.00 |
DisclosureSEC source: 0001127602-19-016490 · form4.xml · derivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,519 Underlying: Common Stock · 6,519 shares Expires 2029-04-26 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 21:32 UTC | Bio Green Med Solution, Inc. CYCC · Entity 8225 | GrantStock Option (right to buy) · Derivative | 8,576 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0001144204-18-032715 · tv495793_form4.xml · derivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,576 Underlying: Common Stock · 8,576 shares Expires 2028-05-31 F1 · price: These options were granted to Dr. Barker for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc. Read SEC document |
| April 27, 2018 Filed Apr 27, 2018 21:36 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 2,857 | $0.00 Strike: $7.80 | $0.00 |
DisclosureSEC source: 0001127602-18-015441 · form4.xml · derivative · entry 2 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,857 Underlying: Common Stock · 2,857 shares Expires 2028-04-27 F1 · derivative.exercise_date: Option vests with respect to 1/12th of the shares subject to the option for each month of service following the date of grant. Read SEC document |
| April 27, 2018 Filed Apr 27, 2018 21:36 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantCommon Stock | 2,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-015441 · form4.xml · nonDerivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,187 Read SEC document |
| September 15, 2017 Filed Sep 18, 2017 10:36 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 1,000 | $12.50 | $12,500.00 |
DisclosureSEC source: 0001127602-17-027538 · form4.xml · nonDerivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,623 Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 21:04 UTC | Bio Green Med Solution, Inc. CYCC · Entity 8225 | GrantStock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $4.38 | $0.00 |
DisclosureSEC source: 0001571049-17-005584 · t1701732_x2-f4.xml · derivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2027-05-30 F1 · price: These options were granted to Dr. Barker for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc. Read SEC document |
| April 28, 2017 Filed May 1, 2017 20:48 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 2,857 | $0.00 Strike: $15.61 | $0.00 |
DisclosureSEC source: 0001127602-17-016055 · form4.xml · derivative · entry 2 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,857 Underlying: Common Stock · 2,857 shares Expires 2027-04-28 F1 · derivative.exercise_date: Option vests with respect to 1/12th of the shares subject to the option for each month of service following the date of grant. Read SEC document |
| April 28, 2017 Filed May 1, 2017 20:48 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantCommon Stock | 1,281 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-016055 · form4.xml · nonDerivative · entry 1 BARKER SAM L · CIK 0001226877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,623 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.